Search research articles
Contact Us
Filters
Showing results (1-10 of 103) with videos related to
Page
of 11
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 17, 2019
Outpatient Parenteral Antibiotic Treatment for Infective Endocarditis: Insights From Real Life
Pierre Tattevin, Matthieu Revest
Travel Medicine and Infectious Disease
|
July 7, 2020
No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France"
David Lebeaux, Matthieu Revest
La Revue Du Praticien
|
December 5, 2018
[Treatment of tuberculosis: what's new?]
Matthieu Revest, Marion Baldeyrou, Pierre Tattevin
La Revue Du Praticien
|
May 31, 2012
[The natural story of tuberculosis]
Hélène Leroy, Matthieu Revest, Pierre Tattevin
The American Journal of Medicine
|
January 3, 2015
The reply
Pierre Fillatre, Matthieu Revest, Pierre Tattevin
Presse Medicale (Paris, France : 1983)
|
March 23, 2010
[Major hyperferritinemia, autoimmune thrombocytopenic purpura and lymphocytic lymphoma in Gaucher disease]
Bernard Grosbois, Matthieu Revest, Olivier Decaux
Archives of Internal Medicine
|
January 27, 2010
Can we really achieve a 1-year mortality rate lower than 10% in patients with infective endocarditis?
Pierre Tattevin, Erwan Donal, Matthieu Revest
La Revue Du Praticien
|
June 14, 2014
[Vascular prostheses-related infections]
Matthieu Revest, Solène Patrat-Delon, Pierre Tattevin
La Revue Du Praticien
|
June 23, 2021
["Why is proper use particularly important for the therapeutic class of anti-infective drugs?"]
Léa Picard, Solène Patrat-Delon, Matthieu Revest
La Revue Du Praticien
|
January 16, 2014
[Antibiotic prescription and surveillance]
Solène Patrat-Delon, Matthieu Revest, Pierre Tattevin
Page
of 11
Search research articles
Search
Showing results (1-10 of 103) with videos related to
Sort By:
Page
of 11
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 17, 2019
Outpatient Parenteral Antibiotic Treatment for Infective Endocarditis: Insights From Real Life
Pierre Tattevin, Matthieu Revest
Travel Medicine and Infectious Disease
|
July 7, 2020
No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France"
David Lebeaux, Matthieu Revest
La Revue Du Praticien
|
December 5, 2018
[Treatment of tuberculosis: what's new?]
Matthieu Revest, Marion Baldeyrou, Pierre Tattevin
La Revue Du Praticien
|
May 31, 2012
[The natural story of tuberculosis]
Hélène Leroy, Matthieu Revest, Pierre Tattevin
The American Journal of Medicine
|
January 3, 2015
The reply
Pierre Fillatre, Matthieu Revest, Pierre Tattevin
Presse Medicale (Paris, France : 1983)
|
March 23, 2010
[Major hyperferritinemia, autoimmune thrombocytopenic purpura and lymphocytic lymphoma in Gaucher disease]
Bernard Grosbois, Matthieu Revest, Olivier Decaux
Archives of Internal Medicine
|
January 27, 2010
Can we really achieve a 1-year mortality rate lower than 10% in patients with infective endocarditis?
Pierre Tattevin, Erwan Donal, Matthieu Revest
La Revue Du Praticien
|
June 14, 2014
[Vascular prostheses-related infections]
Matthieu Revest, Solène Patrat-Delon, Pierre Tattevin
La Revue Du Praticien
|
June 23, 2021
["Why is proper use particularly important for the therapeutic class of anti-infective drugs?"]
Léa Picard, Solène Patrat-Delon, Matthieu Revest
La Revue Du Praticien
|
January 16, 2014
[Antibiotic prescription and surveillance]
Solène Patrat-Delon, Matthieu Revest, Pierre Tattevin
Page
of 11